SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the United States Food and Drug Administration (FDA) provided an interim response to the company’s formal dispute ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback